Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2012 - 2026)

Pacific Biosciences Of California's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $8.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (changed N/A YoY), while the FY2024 annual figure was $546000.0, down 97.21% from the prior year.
• Other Non-Current Liabilities was $8.0 million for Q1 2026 at Pacific Biosciences Of California, up from $546000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $186.3 million in Q2 2023 to a low of $546000.0 in Q4 2024.
• Historically, Other Non-Current Liabilities has averaged $70.9 million across 4 years, with a median of $19.5 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities jumped 22327.39% in 2022, then sank 99.59% in 2024.
• A 4-year view of Other Non-Current Liabilities shows it stood at $1.3 million in 2022, then surged by 1403.85% to $19.6 million in 2023, then plunged by 97.21% to $546000.0 in 2024, then surged by 1365.2% to $8.0 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $8.0 million (Q1 2026), $546000.0 (Q4 2024), and $751000.0 (Q3 2024), per Business Quant data.